Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Ludwig Oxford's Dr Tammie Bishop organised a week of work experience for fifteen year 12 students in collaboration with the Magdalen Outreach Team. University Research Lecturer Dr Tammie Bishop works in the laboratory led by 2019 Nobel Prize-winning Sir Peter Ratcliffe (Target Discovery Institute & Ludwig Institute for Cancer Research) which conducts research into hypoxia, as well as currently being involved in research into the role of hypoxia in SARS-CoV-2.

Scientist looking through a microscope

Dr Tammie Bishop organised a week of work experience for fifteen year 12 students in collaboration with the Magdalen Outreach Team.

University Research Lecturer Dr Tammie Bishop works in the laboratory led by 2019 Nobel Prize-winning Sir Peter Ratcliffe (Target Discovery Institute & Ludwig Institute for Cancer Research) which conducts research into hypoxia, as well as currently being involved in research into the role of hypoxia in SARS-CoV-2. Usually work experience would be held in the lab in person but this year it was successfully transferred into an online format, enabling students from across the country to take part.

The opportunity was offered by competitive application to students in Magdalen College’s seven link regions and participants joined from both the London and northern areas. The week involved lectures and workshops delivered by Tammie and her team (including Isobel Argles, Dr Thomas Keeley, Samvid Kurlekar and Maria Prange-Barczynska) as well as requiring students to produce their own work including presentations, experiment ideas and essays. 

Tammie said of the programme, ‘Students visit the lab each summer for work experience and we didn’t want them to miss out on this opportunity – COVID-19 or not! We came up with the idea of running a ‘remote’ work experience week as an alternative, to try to give students a taster for research and University life. The event was extremely fun and valuable for participants and organisers alike and we look forward to running it again next year.’

 The week introduced the group to the range of medical courses offered at Oxford including a Biomedicine and Medicine Q&A with Prof Rob Gilbert and a mock tutorial with Samvid Kurlekar. The group of students were also introduced to topics they hadn’t studied before such as the Hypoxia-Inducible Factor (HIF) pathway and recent work on the role of hypoxia in COVID-19. They even participated in a ‘live’ demonstration of lab work using cell cultures with Junior Research Fellow, Dr Thomas Keeley. As part of the week, they also received personalised essay and personal statement feedback to help them with their university applications.

One participant, Jana, said about the event, ‘I am very grateful for this fantastic opportunity as I have learnt so much within a week. The workshops, lectures, Q&A sessions, feedback and the work that has been set were very informative and interesting to me, where I was able to significantly benefit from and come out of this experience with some new knowledge- that is very exciting.’

Magdalen College Senior Outreach and Access Officer, Olivia Webster, said that ‘Worries about not having work experience is one of the main questions we’ve received from prospective applicants, especially applicants for Medicine, since lockdown begun. This is why the work experience Tammie and her team have provided is so vital and it was made even better by the fact our students from our northern schools could participate due to the digital format. We hope to continue this collaborative project in the years to come.’

More on Magdalen College Outreach on their website.

Similar stories

World’s largest clinical trial for COVID-19 treatments expands internationally

News

The Randomised Evaluation of COVID-19 Therapy (RECOVERY) Trial, the world’s largest clinical trial for COVID-19 treatments, has now expanded internationally with Indonesia and Nepal among the first countries to join and recruited to RECOVERY International. NDM's Peter Horby, Professor of Emerging Infectious Diseases and Global Health, and Joint Chief Investigator for the trial, said ‘The RECOVERY trial has been an enormous success, enrolling over 36,000 patients and delivering clear results on six treatments already. By building on this success through international partnership we can speed up the assessment of novel treatments, increase the global relevance of the trial results, build capacity, and reduce wasted efforts on small uninformative studies".

Exscientia and the University of Oxford announce partnership to develop treatments for Alzheimer’s disease

News

Exscientia, the leading AI Drug Discovery company, has today announced its collaboration with the Alzheimer’s Research UK Oxford Drug Discovery Institute (ARUK-ODDI) to develop medicines targeting neuroinflammation for the treatment of Alzheimer’s disease (AD).

Tocilizumab reduces deaths in patients hospitalised with COVID-19

News

The Randomised Evaluation of COVID-19 Therapy (RECOVERY) has demonstrated that an anti-inflammatory treatment, tocilizumab, reduces the risk of death when given to hospitalised patients with severe COVID-19.

Common asthma treatment reduces need for hospitalisation in COVID-19 patients, study suggests

News

Early treatment with a medication commonly used to treat asthma appears to significantly reduce the need for urgent care and hospitalisation in people with COVID-19, researchers at the University of Oxford have found.

Oxford Cancer Centre appoints Professor Tim Elliot as new co-director

News

The CRUK Oxford Centre is pleased to announce the appointment of Professor Tim Elliot as its new co-Director. Tim has recently joined the Nuffield Department of Medicine and Oriel College as the Kidani Professor of Immuno-Oncology. He re-joins the Oxford community from Southampton University, having previously completed his undergraduate degree in Biochemistry at Balliol and subsequently holding a Professorial post at the Weatherall Institute for Molecular Medicine.

Lateral flow devices detect most infectious COVID-19 cases and could allow a safer relaxation of the current lockdown

News

Researchers from NDM's Big Data Institute working with Public Health England and NHS Test and Trace, have used Test and Trace data to find out why some individuals pass COVID-19 on to their contacts more easily than others, and if lateral flow tests are sufficient in detecting those who are most infectious